CDSCO UID IMP/IVD/2019/000089_fd678b26f00c43507dac1181dfa068d4_f03e00149ad60b7d1bfb8661e01686b6LIAISON® PSA
- UID
- IMP/IVD/2019/000089_fd678b26f00c43507dac1181dfa068d4_f03e00149ad60b7d1bfb8661e01686b6
- Device class
- Class C
- Brand name
- LIAISON® Tg II Gen Confirmatory
- License holder
- Diasorin Healthcare India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- In vitro assay for the quantitative determination of human prostate-specific antigen (LIAISON® Tg II Gen Confirmatory) in human serum and plasma (LIAISON® Tg II Gen Confirmatory) during the follow-up of patients with carcinoma of the prostate. The test has to be performed on the LIAISON® Analyzer family
LIAISON® PSA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000089_fd678b26f00c43507dac1181dfa068d4_f03e00149ad60b7d1bfb8661e01686b6. This device is marketed under the brand name LIAISON® Tg II Gen Confirmatory. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.